CIP
IRMD icon

Cornerstone Investment Partners’s iRadimed IRMD Stock Holding History

Cornerstone Investment Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Buy
2,976
+673
+29% +$67.3K 0.01% 146
2025
Q4 		$224K Buy
+2,303
New +$198K 0.01% 151

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Investment Partners's IRMD Position: Q1 2026 in Review

Cornerstone Investment Partners increased its iRadimed (IRMD) stake by 29% in Q1 2026, buying an estimated $67.3K and bringing the position to 2,976 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #146.

Cornerstone Investment Partners first reported a position in IRMD in Q4 2025 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Cornerstone Investment Partners held 2,976 shares of iRadimed worth $286K as of Q1 2026.
  • Cornerstone Investment Partners bought 673 iRadimed shares in Q1 2026, an estimated $67.3K.
  • iRadimed made up 0.01% of Cornerstone Investment Partners's portfolio in Q1 2026, its #146 holding.
  • Cornerstone Investment Partners first reported a position in iRadimed in Q4 2025 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Cornerstone Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.